Teva Pharmaceuticals
TEVA
TEVA
454 hedge funds and large institutions have $7.13B invested in Teva Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 131 increasing their positions, 146 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
2% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 58
4% less call options, than puts
Call options by funds: $324M | Put options by funds: $338M
10% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 146
Holders
454
Holding in Top 10
12
Calls
$324M
Puts
$338M
Top Buyers
| 1 | +$128M | |
| 2 | +$86.6M | |
| 3 | +$81.7M | |
| 4 |
IAM
Ion Asset Management
Herzliya,
Israel
|
+$63.8M |
| 5 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$38.3M |
Top Sellers
| 1 | -$82.1M | |
| 2 | -$67.4M | |
| 3 | -$18.1M | |
| 4 |
Millennium Management
New York
|
-$13.5M |
| 5 |
HM
HealthCor Management
New York
|
-$13.4M |